a month ago
AUTL
AnalystsGil BlumGil Blum's Stock Forecasts
AnalystsGil Blum
Sectors:
Industries:
Analyst Ranking
Top 1%
#19 out of 4587 analysts
Average Return
+22.46%
Win Rate
56%144 out of 255
Risk vs Reward
Poor
Good
Gil Blum's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Taysha Gene Therapies IncTSHA | +364.66% | $0.67 | $3.09 | 2023-06-29 - 2024-05-17 | Buy |
Mereo Biopharma Group PLCMREO | +364.14% | $0.71 | $3.30 | 2023-03-30 - 2024-03-28 | Buy |
Taysha Gene Therapies IncTSHA | +341.54% | $0.65 | $2.87 | 2023-03-29 - 2024-03-28 | Buy |
Cti Biopharma CorpCTIC | +267.07% | $1.64 | $6.02 | 2021-12-01 - 2022-11-30 | Buy |
Shattuck Labs IncSTTK | +264.75% | $2.17 | $7.92 | 2023-08-11 - 2024-05-17 | Buy |
Gil Blum Analyst Color
Get additional color on Gil Blum's coverage of popular stocks
2 months ago
AUTL
Gil Blum's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Autolus Therapeutics PLCAUTL | 18 | Buy | $9.00 | +105.01% | Reiterates | 2 days ago |
Mereo Biopharma Group PLCMREO | 10 | Buy | $6.00 | +87.50% | Reiterates | 4 days ago |
Celcuity IncCELC | 9 | Buy | $24.00 | +43.20% | Reiterates | 4 days ago |
Taysha Gene Therapies IncTSHA | 16 | Buy | $7.00 | +126.54% | Reiterates | 5 days ago |
Generation Bio CoGBIO | 11 | Buy | $10.00 | +173.22% | Reiterates | 5 days ago |
Nurix Therapeutics IncNRIX | 15 | Buy | $31.00 | +86.86% | Reiterates | 5 days ago |
Nkarta IncNKTX | 11 | Buy | $13.00 | +99.08% | Maintains | 6 days ago |
Tscan Therapeutics IncTCRX | 1 | Buy | $11.00 | +22.49% | Reiterates | 7 days ago |
Arcellx IncACLX | 15 | Buy | $81.00 | +51.06% | Reiterates | 9 days ago |
Recursion Pharmaceuticals IncRXRX | 14 | Buy | $17.00 | +80.47% | Reiterates | 10 days ago |
Crispr Therapeutics AgCRSP | 13 | Buy | $88.00 | +56.53% | Maintains | 11 days ago |
Immunocore Holdings PLCIMCR | 4 | Buy | $81.00 | +52.00% | Reiterates | 11 days ago |
Cartesian Therapeutics IncRNAC | 11 | Buy | $42.00 | +58.91% | Reiterates | 11 days ago |
Rocket Pharmaceuticals IncRCKT | 13 | Buy | $53.00 | +134.31% | Reiterates | 13 days ago |
Nextcure IncNXTC | 8 | Buy | $4.00 | +139.52% | Reiterates | 16 days ago |
Shattuck Labs IncSTTK | 10 | Buy | $12.00 | +51.61% | Reiterates | 17 days ago |
Geron CorpGERN | 15 | Buy | $5.00 | +31.23% | Reiterates | 17 days ago |
Sarepta Therapeutics IncSRPT | 19 | Buy | $166.00 | +26.35% | Reiterates | 18 days ago |
G1 Therapeutics IncGTHX | 13 | Buy | $12.00 | +164.90% | Reiterates | 18 days ago |
I MabIMAB | 12 | Buy | $6.00 | +242.86% | Reiterates | a month ago |
Gamida Cell LtdGMDAQ | 8 | Buy | $6.00 | +18,081.82% | Reiterates | 5 months ago |
Cti Biopharma CorpCTIC | 5 | Buy | $9.00 | N/A | Reiterates | a year ago |
Avrobio IncAVRO | 4 | Buy | $6.00 | N/A | Reiterates | a year ago |
Fate Therapeutics IncFATE | 1 | Hold | N/A | N/A | Initiates Coverage On | 2 years ago |
Spyre Therapeutics IncSYRE | 1 | Buy | $225.00 | N/A | Maintains | 2 years ago |
Amicus Therapeutics IncFOLD | 1 | Hold | N/A | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.